Literature DB >> 9108313

Androgen regulation of ornithine decarboxylase in human prostatic cells identified using differential display.

A M Betts1, I Waite, D E Neal, C N Robson.   

Abstract

Androgens are essential for normal prostate physiology and have a permissive role in the development and progression of prostate cancer. Using the mRNA differential display technique, ornithine decarboxylase (ODC) was identified to be up-regulated by androgens in human prostatic LNCaP cells. On Northern analysis, the induction of ODC expression by 10 nM androgen was rapid and continued up to 48 h exposure with a maximum 6.3-fold up-regulation. The anti-androgen Casodex inhibited the androgen-induced up-regulation of ODC, whereas the protein synthesis inhibitor cycloheximide did not. Together these data suggest that regulation is mediated through the androgen receptor protein and does require secondary protein synthesis, respectively. The kinetics of induction of ODC were almost identical to those of prostate specific antigen. Taken together these data suggest that ODC is directly regulated by androgens in LNCaP cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108313     DOI: 10.1016/s0014-5793(97)00209-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Polyamines transduce the nongenomic, androgen-induced calcium sensitization in intestinal smooth muscle.

Authors:  María C González-Montelongo; Raquel Marín; José A Pérez; Tomás Gómez; Mario Díaz
Journal:  Mol Endocrinol       Date:  2013-09-03

2.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

3.  Effect of parathyroid hormone related protein, and dihydrotestosterone on proliferation and ornithine decarboxylase mRNA in human prostate cancer cell lines.

Authors:  F Asadi; M Faraj; S Malakouti; S C Kukreja
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

4.  The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Authors:  Anne R Simoneau; Eugene W Gerner; Ray Nagle; Argyrios Ziogas; Sharon Fujikawa-Brooks; Hagit Yerushalmi; Thomas E Ahlering; Ronald Lieberman; Christine E McLaren; Hoda Anton-Culver; Frank L Meyskens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-02       Impact factor: 4.254

5.  Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis.

Authors:  Donatella Coradduzza; Tatiana Solinas; Emanuela Azara; Nicola Culeddu; Sara Cruciani; Angelo Zinellu; Serenella Medici; Margherita Maioli; Massimo Madonia; Ciriaco Carru
Journal:  Biomolecules       Date:  2022-03-29

6.  Transcriptional programs activated by exposure of human prostate cancer cells to androgen.

Authors:  Samuel E DePrimo; Maximilian Diehn; Joel B Nelson; Robert E Reiter; John Matese; Mike Fero; Robert Tibshirani; Patrick O Brown; James D Brooks
Journal:  Genome Biol       Date:  2002-06-14       Impact factor: 13.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.